1. Home
  2. BNZI vs CDT Comparison

BNZI vs CDT Comparison

Compare BNZI & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$1.15

Market Cap

9.6M

Sector

N/A

ML Signal

HOLD

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$1.75

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
CDT
Founded
2016
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
3.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNZI
CDT
Price
$1.15
$1.75
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$23.00
N/A
AVG Volume (30 Days)
499.4K
410.7K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,650,176.00
N/A
Revenue This Year
$223.24
N/A
Revenue Next Year
$31.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
147.06
N/A
52 Week Low
$1.09
$1.48
52 Week High
$27.00
$2,198.40

Technical Indicators

Market Signals
Indicator
BNZI
CDT
Relative Strength Index (RSI) 34.70 44.05
Support Level $1.14 $1.69
Resistance Level $1.37 $2.33
Average True Range (ATR) 0.12 0.25
MACD 0.04 0.01
Stochastic Oscillator 11.76 31.76

Price Performance

Historical Comparison
BNZI
CDT

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: